Many investigators have extensively studied the clinical value of TILs or RS in breast cancer; however, there are only a few studies regarding an association between Oncotype DX-RS and TILs in a specific subset of breast cancer, ER-positive/HER2-negative breast cancer. Here, ESR1 is linked to breast carcinoma.